The levels of NAIP, BIRC2, XIAP, and BIRC6 were significantly elevated in the subgroups of tumor stages 1-3 compared to their levels in the normal subgroups (Figure 2A), with no discernible differences in their levels in the subgroup of tumor stage 4. This evidence concerns the gene BIRC6 and neoplasm.